David Philip Hudesman MD
Inflammatory Bowel Disease
Professor of Medicine, NYU School of Medicine Director, Inflammatory Bowel Disease Center at NYU Langone Health
Join to View Full Profile
305 East 33rd StreetNew York, NY 10016
Dr. Hudesman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai/Morningside/WestFellowship, Gastroenterology, 2008 - 2011- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2005 - 2008
Rutgers New Jersey Medical SchoolClass of 2005
Certifications & Licensure
NY State Medical License 2007 - 2026
CT State Medical License 2022 - 2024
FL State Medical License 2022 - 2024
PA State Medical License 2022 - 2024
American Board of Internal Medicine Gastroenterology
Clinical Trials
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
- Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples Start of enrollment: 2018 Dec 04
Publications & Presentations
PubMed
- Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and pr...Siddharth Singh, Jasmine D Nguyen, David I Fudman, Mark E Gerich, Samir A Shah
BMJ Open Gastroenterology. 2025-03-31 - Increasing Exposure to Inflammatory Bowel Diseases Education in Gastroenterology Fellowship: The Pilot IBD 101 Experience.Lisa Malter, Simon J Hong, Sarah Lopatin, Megan Murphy, David Hudesman
Inflammatory Bowel Diseases. 2025-03-03 - 3 citationsOlder Adults With Inflammatory Bowel Disease Are at Higher Risk of Developing Antibodies to Infliximab.Adam S Faye, Kate E Lee, David Hudesman, Thierry Dervieux
Inflammatory Bowel Diseases. 2024-12-05
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumGursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
Press Mentions
Innovative Gastroenterologist Will Lead Pediatric Inflammatory Bowel Disease Program at Hassenfeld Children’s Hospital at NYU LangoneMarch 4th, 2025- IBD Drive Time: David Hudesman, MD, on Work Productivity in IBDSeptember 19th, 2024
- Ulcerative Colitis: AI Program Shows Promise in Predicting Flare-UpsMarch 7th, 2023
- Join now to see all
Committees
- Cochair, CCFA Medical Advisory Committee - NYC Chapter
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
